JP2009528371A5 - - Google Patents

Download PDF

Info

Publication number
JP2009528371A5
JP2009528371A5 JP2008557405A JP2008557405A JP2009528371A5 JP 2009528371 A5 JP2009528371 A5 JP 2009528371A5 JP 2008557405 A JP2008557405 A JP 2008557405A JP 2008557405 A JP2008557405 A JP 2008557405A JP 2009528371 A5 JP2009528371 A5 JP 2009528371A5
Authority
JP
Japan
Prior art keywords
azabicyclo
benzamide
endo
oct
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008557405A
Other languages
English (en)
Japanese (ja)
Other versions
JP5086280B2 (ja
JP2009528371A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/005388 external-priority patent/WO2007103187A2/en
Publication of JP2009528371A publication Critical patent/JP2009528371A/ja
Publication of JP2009528371A5 publication Critical patent/JP2009528371A5/ja
Application granted granted Critical
Publication of JP5086280B2 publication Critical patent/JP5086280B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008557405A 2006-03-01 2007-02-28 ミューオピオイド受容体拮抗剤としての8−アザビシクロ[3.2.1]オクタン化合物 Active JP5086280B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US77796206P 2006-03-01 2006-03-01
US60/777,962 2006-03-01
US84102806P 2006-08-30 2006-08-30
US60/841,028 2006-08-30
PCT/US2007/005388 WO2007103187A2 (en) 2006-03-01 2007-02-28 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012171119A Division JP2012211193A (ja) 2006-03-01 2012-08-01 ミューオピオイド受容体拮抗剤としての8−アザビシクロ[3.2.1]オクタン化合物

Publications (3)

Publication Number Publication Date
JP2009528371A JP2009528371A (ja) 2009-08-06
JP2009528371A5 true JP2009528371A5 (cg-RX-API-DMAC10.html) 2010-04-08
JP5086280B2 JP5086280B2 (ja) 2012-11-28

Family

ID=38436795

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008557405A Active JP5086280B2 (ja) 2006-03-01 2007-02-28 ミューオピオイド受容体拮抗剤としての8−アザビシクロ[3.2.1]オクタン化合物
JP2012171119A Withdrawn JP2012211193A (ja) 2006-03-01 2012-08-01 ミューオピオイド受容体拮抗剤としての8−アザビシクロ[3.2.1]オクタン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012171119A Withdrawn JP2012211193A (ja) 2006-03-01 2012-08-01 ミューオピオイド受容体拮抗剤としての8−アザビシクロ[3.2.1]オクタン化合物

Country Status (24)

Country Link
US (11) US7622508B2 (cg-RX-API-DMAC10.html)
EP (1) EP2001876B1 (cg-RX-API-DMAC10.html)
JP (2) JP5086280B2 (cg-RX-API-DMAC10.html)
KR (1) KR101376479B1 (cg-RX-API-DMAC10.html)
AR (1) AR059690A1 (cg-RX-API-DMAC10.html)
AT (1) ATE509928T1 (cg-RX-API-DMAC10.html)
AU (1) AU2007224213B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0708490B8 (cg-RX-API-DMAC10.html)
CA (1) CA2646409C (cg-RX-API-DMAC10.html)
CY (1) CY1111747T1 (cg-RX-API-DMAC10.html)
DK (1) DK2001876T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20110590T1 (cg-RX-API-DMAC10.html)
IL (1) IL193690A (cg-RX-API-DMAC10.html)
MA (1) MA30284B1 (cg-RX-API-DMAC10.html)
MX (1) MX2008011165A (cg-RX-API-DMAC10.html)
MY (1) MY145633A (cg-RX-API-DMAC10.html)
NZ (1) NZ570764A (cg-RX-API-DMAC10.html)
PE (1) PE20071311A1 (cg-RX-API-DMAC10.html)
PL (1) PL2001876T3 (cg-RX-API-DMAC10.html)
PT (1) PT2001876E (cg-RX-API-DMAC10.html)
RU (1) RU2423362C2 (cg-RX-API-DMAC10.html)
SI (1) SI2001876T1 (cg-RX-API-DMAC10.html)
TW (1) TWI379832B (cg-RX-API-DMAC10.html)
WO (1) WO2007103187A2 (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY145633A (en) * 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TWI409067B (zh) 2007-02-28 2013-09-21 Theravance Inc 8-氮雜雙環〔3.2.1〕辛烷化合物之結晶型
TWI415850B (zh) * 2007-07-20 2013-11-21 Theravance Inc 製備mu類鴉片受體拮抗劑之中間物的方法
US7947710B2 (en) * 2007-08-27 2011-05-24 Theravance, Inc. Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
US7902221B2 (en) * 2007-08-27 2011-03-08 Theravance, Inc. Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TWI423801B (zh) 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之8-氮雜雙環〔3.2.1〕辛基-2-羥基苯甲醯胺化合物
ES2465621T3 (es) * 2007-08-27 2014-06-06 Theravance, Inc. Compuestos de heteroarilalquil-8-azabiciclo[3.2.1]octano, como antagonistas de los receptores opiodes mu
US20110071163A1 (en) * 2009-09-18 2011-03-24 Adolor Corporation Use of an opioid receptor antagonist for the treatment or prevention of gastrointestinal tract disorders
US20120122928A1 (en) 2010-08-11 2012-05-17 Bayer Cropscience Ag Heteroarylpiperidine and -Piperazine Derivatives as Fungicides
EP2423210A1 (de) 2010-08-25 2012-02-29 Bayer CropScience AG Heteroarylpiperidin- und -piperazinderivate als Fungizide
US8759527B2 (en) 2010-08-25 2014-06-24 Bayer Cropscience Ag Heteroarylpiperidine and -piperazine derivatives as fungicides
EP2632922B1 (de) 2010-10-27 2019-02-27 Bayer CropScience Aktiengesellschaft Heteroarylpiperidin und -piperazinderivate als fungizide
JP5703009B2 (ja) * 2010-12-16 2015-04-15 住友精化株式会社 スルホン化合物、スルホン化合物の製造方法、および電気化学デバイス用電解液
WO2012104273A1 (de) 2011-02-01 2012-08-09 Bayer Cropscience Ag Heteroarylpiperidin und -piperazinderivate als fungizide
US10004232B2 (en) 2011-09-15 2018-06-26 Bayer Intellectual Property Gmbh Piperidine pyrazoles as fungicides
ES2695233T3 (es) 2011-12-27 2019-01-02 Bayer Cropscience Ag Derivados de isoxazol
US9192570B2 (en) 2013-12-20 2015-11-24 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
US20160287573A1 (en) 2015-04-02 2016-10-06 Theravance Biopharma R&D Ip, Llc Combination dosage form of a mu opioid receptor antagonist and an opioid agent
US10604489B2 (en) 2018-02-05 2020-03-31 Alkermes, Inc. Compounds for the treatment of pain
KR20230154789A (ko) * 2020-11-06 2023-11-09 액티노젠 메디컬 리미티드 헤테로고리 메탄온 화합물 및 그의 아자-비시클로 중간체의 제조 공정

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1067824B (de) * 1954-10-20 1959-10-29 Sandoz Ag Verfahren zur Herstellung saeureamidartiger Tropanabkoemmlinge
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
UA58476C2 (uk) * 1997-10-09 2003-08-15 Санофі-Сентелябо Похідні 8-азабіцикло[3.2.1]октан-3-метанаміну, фармацевтична композиція та лікарський засіб
US6900228B1 (en) * 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
GB9810671D0 (en) * 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
TWI244481B (en) * 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
GB9912410D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US6469030B2 (en) * 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
US20030181447A1 (en) * 2001-02-22 2003-09-25 Boyd Robert E. 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
US6552036B2 (en) 2000-03-03 2003-04-22 Ortho-Mcneil Pharmaceutical, Inc. 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
US20020025948A1 (en) * 2000-06-23 2002-02-28 Banks Bernard Joseph 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
US7375115B2 (en) * 2001-10-09 2008-05-20 Kyorin Pharmaceutical Co., Ltd. 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
JP4155522B2 (ja) * 2001-10-22 2008-09-24 ファイザー・プロダクツ・インク オピオイド受容体アンタゴニストとしての3−アザビシクロ(3.1.0)ヘキサン誘導体
US7381721B2 (en) * 2003-03-17 2008-06-03 Adolor Corporation Substituted piperidine compounds
BRPI0409307A (pt) * 2003-04-14 2006-04-25 Pfizer Prod Inc derivados de 3-azabiciclo[3.2.1]octano
US20040204453A1 (en) * 2003-04-14 2004-10-14 Pfizer Inc 4-Phenyl-piperidine compounds and their use as modulators of opioid receptors
US7056930B2 (en) * 2003-04-14 2006-06-06 Pfizer Inc. 2-Azabicyclo[3.3.1]nonane derivatives
BRPI0409570A (pt) * 2003-04-15 2006-04-18 Pfizer Prod Inc derivados de 3-benzidrilideno-8-aza-biciclo[3.2.1]octano com atividade receptora de opióides
US6992090B2 (en) * 2003-06-16 2006-01-31 Adolor Corporation Substituted piperidine compounds and methods of their use
WO2005075472A1 (en) 2004-02-03 2005-08-18 Janssen Pharmaceutica, N.V. 3-(diheteroarylnethylene)-8-azabicyclo[3.2.1]octane and 3-(aryl)(heteroaryl)methylene)-8-azabicyclo[3.2.1]octane derivatives
US7087749B2 (en) * 2004-03-11 2006-08-08 Adolor Corporation Substituted piperidine compounds and methods of their use
US7538110B2 (en) * 2005-10-27 2009-05-26 Adolor Corporation Opioid antagonists
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
JP2010509227A (ja) 2006-11-07 2010-03-25 ネクター セラピューティックス エイエル,コーポレイション オピオイド作動薬およびオピオイド拮抗薬の用量形態および同時投与
TWI409067B (zh) * 2007-02-28 2013-09-21 Theravance Inc 8-氮雜雙環〔3.2.1〕辛烷化合物之結晶型
TWI415850B (zh) 2007-07-20 2013-11-21 Theravance Inc 製備mu類鴉片受體拮抗劑之中間物的方法
US7947710B2 (en) 2007-08-27 2011-05-24 Theravance, Inc. Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TWI423801B (zh) 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之8-氮雜雙環〔3.2.1〕辛基-2-羥基苯甲醯胺化合物
US7902221B2 (en) 2007-08-27 2011-03-08 Theravance, Inc. Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
ES2465621T3 (es) 2007-08-27 2014-06-06 Theravance, Inc. Compuestos de heteroarilalquil-8-azabiciclo[3.2.1]octano, como antagonistas de los receptores opiodes mu

Similar Documents

Publication Publication Date Title
HRP20110590T1 (hr) Spojevi 8-azabiciklo[3.2.1]oktana kao antagonisti mu opioidnih receptora
JP3664492B2 (ja) タチキニン nk▲下3▼ 受容体アンタゴニストとしてのキノリン誘導体
JP2008510828A5 (cg-RX-API-DMAC10.html)
JP2013510883A5 (cg-RX-API-DMAC10.html)
JP2007518738A5 (cg-RX-API-DMAC10.html)
RU2008100606A (ru) Ингибиторы сфингозинкиназы
JP2008526999A5 (cg-RX-API-DMAC10.html)
HUP0401876A2 (hu) Béta2 adrenerg receptor agonista hatású aril-anilin-származékok, valamint ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
JP2009538910A5 (cg-RX-API-DMAC10.html)
JP2006505543A5 (cg-RX-API-DMAC10.html)
JP2008515852A5 (cg-RX-API-DMAC10.html)
RU2004127925A (ru) N3-алкилированные бензимидазольные производные в качестве ингибиторов мек
JP2007509852A5 (cg-RX-API-DMAC10.html)
JP2010501478A5 (cg-RX-API-DMAC10.html)
JP2010501584A5 (cg-RX-API-DMAC10.html)
JP2008501705A5 (cg-RX-API-DMAC10.html)
JP2013503846A5 (cg-RX-API-DMAC10.html)
JP2010155827A5 (cg-RX-API-DMAC10.html)
JP2010535858A5 (cg-RX-API-DMAC10.html)
JP2007505931A5 (cg-RX-API-DMAC10.html)
JP2010513434A5 (cg-RX-API-DMAC10.html)
CA2471578A1 (en) Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
JP2015508092A5 (cg-RX-API-DMAC10.html)
JP2012508249A5 (cg-RX-API-DMAC10.html)
JP2011521938A5 (cg-RX-API-DMAC10.html)